A project has been launched to develop a new European guideline for the treatment of sarcoïdosis. Patients are being invited to share their priorities.
The sarcoidosis treatment guideline is being developed by the European Respiratory Society (ERS). The project is based on a collaboration between European and American doctors.
To help with this, ERS would like to find out the outcomes that are most important to patients, to make sure that the recommendations in the guideline take into account aspects of treatment which matter to patients.
The American Foundation for Sarcoidosis Research is calling on sarcoidosis patients to participate in a brief ERS survey (2 to 5 minutes).
The survey will close on February 23, 2018. It is available in English, Spanish, French, Italian, German and Dutch.